Oncology Today with Dr Neil Love cover image

Management of HER2-Altered Non-Small Cell Lung Cancer

Oncology Today with Dr Neil Love

00:00

Is It a Randomized Control or an EJFR?

It's really a chemotherapy delivery system. So it's a bit different to the tyrosine kinase. randomized control trials still play an important role. And we're hoping that there's the lungo fall, which is the first line trial, will produce superior outcomes. But the jury's still out.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app